Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Algorithms
New algorithms study findings recently were reported by researchers at Chinese University of Hong Kong, Department of Chemical Pathology
April 13th, 2008
A report, 'A universal algorithm for de novo decrypting of heterozygous indel sequences: a tool for personalized medicine,' is newly published data in Clinica Chimica Acta. According to recent research from Hong Kong, People's Republic of China, "Indels (insertions/deletions) are important DNA sequence variations because of the high frequency in the human genome, the deleterious effects on the reading frame and protein expression, and the association with disease and disease susceptibility of common diseases. In a recent study with a human individual with the whole genome sequenced, 292,102 heterozygous indels and 559,473 homozygous indels were identified." ...
Source: Pharma Investments, Ventures & Law Weekly (2008-04-13)
|
